News & Updates

Breastfeeding protects women against postpartum CVD
Breastfeeding protects women against postpartum CVD
20 Feb 2025 byStephen Padilla

Women who breastfeed, especially those with prior gestational diabetes mellitus (GDM), appear to have greater protection against long-term atherosclerotic cardiovascular disease (ASCVD), suggest the results of a study presented at SMFM 2025.

Breastfeeding protects women against postpartum CVD
20 Feb 2025
Postpartum diuretics use eases persistent hypertension
Postpartum diuretics use eases persistent hypertension
20 Feb 2025
SGLT-2is, GLP-1RAs cut risk of COPD flare-ups
SGLT-2is, GLP-1RAs cut risk of COPD flare-ups
19 Feb 2025 byJairia Dela Cruz

In adults with type 2 diabetes and active chronic obstructive pulmonary disease (COPD), sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) may also reduce the risk of COPD exacerbations, according to a study.

SGLT-2is, GLP-1RAs cut risk of COPD flare-ups
19 Feb 2025
Infliximab trumps other biologics as maintenance drug in CD
Infliximab trumps other biologics as maintenance drug in CD
19 Feb 2025 byStephen Padilla

Among the many biologics used to treat adults with moderate-to-severe Crohn’s disease (CD), infliximab subcutaneous (SC) 120 mg every 2 weeks (Q2W) demonstrates the highest efficacy in clinical remission during maintenance treatment of 52 to 64 weeks’ duration, according to the results of a recent study presented at CCC 2025.

Infliximab trumps other biologics as maintenance drug in CD
19 Feb 2025